Thromb Haemost 2008; 100(06): 958-959
DOI: 10.1160/TH08-10-0683
Editorial Focus
Schattauer GmbH

Difference between sepsis and trauma diagnosed as sensitive diagnostic criteria for disseminated intravascular coagulation

Hideo Wada
1   Department of Molecular and Laboratory Medicine, Me University Graduate School of Medicine, Mie, Japan
,
Tsuyoshi Hatada
2   Department of Emergency Medicine, Me University Graduate School of Medicine, Mie, Japan
› Author Affiliations
Further Information

Publication History

Received: 23 October 2008

Accepted: 23 October 2008

Publication Date:
23 November 2017 (online)

 

 
  • References

  • 1 Colman RW, Robby SJ, Minna JD. Disseminated intravascular coagulation (DIC): an approach. Am J Med 1972; 52: 679-689.
  • 2 Kobayashi N, Maegawa T, Takada M. et al. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haemotol 1983; 49: 265-275.
  • 3 Taylor Jr. FB, Toh CH, Hoots WK. et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation – On behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 2001; 86: 1327-1330.
  • 4 Gando S, Iba T, Eguchi Y. et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006; 34: 625-631.
  • 5 Warren BL, Eid A, Singer P. et al. High-dose antithrombin in severe sepsis. A randomized controlled trial. J Am Med Assoc 2001; 286: 1869-1878.
  • 6 Bernard GR, Vincent JL, Laterre PF. et al. Efficacy and safety of recombinant human proteinC for severe sepsis. N Engl J Med 2001; 08: 699-709.
  • 7 Abraham E, Reinhart K, Opal S. et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. J Am Med Assoc 2003; 290: 238-247.
  • 8 Wada H. Disseminated intravascular coagulation. Clin Chim Acta 2004; 344: 13-21.
  • 9 Kushimoto S, Gando S, Saitoh D. et al. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria: Comparison between sepsis and trauma. Thromb Haemost 2008; 100: 1099-1105.
  • 10 Lozance K, Dejanov I, Mircevski M. Role of coagulopathy in patients with head trauma. J Clin Neurosci 1998; 05: 394-398.
  • 11 Toh CH, Hoots WK. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost 2007; 05: 604-606.
  • 12 Hess JR, Lawson JH. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma 2006; 60: S12-19.